The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,462.00
Bid: 12,460.00
Ask: 12,464.00
Change: 58.00 (0.47%)
Spread: 4.00 (0.032%)
Open: 12,500.00
High: 12,514.00
Low: 12,444.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Aims For 14 Million To Be Offered Covid Jab By Mid-Feb

Tue, 05th Jan 2021 06:49

(Alliance News) - Almost 14 million people in the UK could be in line for a Covid vaccine by the middle of February, in line with plans announced by the prime minister.

In a TV address announcing the third national lockdown for England, Boris Johnson said officials were hoping for all people in the top four priority groups to have been offered a jab in the coming weeks.

Tweeting afterwards, vaccine minister Nadhim Zahawi said the NHS "family will come together" to get 13.9 million doses prepared for the most vulnerable by the middle of next month.

A source told the PA news agency that those near the top of the list will be contacted by mid-February, but the final figure could be lower – closer to 13 million – because of some crossover between groups, such as those over 80 who live in care homes.

Speaking from Downing Street, Johnson outlined the NHS's "realistic expectations" for the vaccination programme in the coming weeks.

He said: "By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination & Immunisation."

Theoretically, this means that all people over the age of 70 should expect to have an inoculation soon, as well as healthcare staff and others who are vulnerable.

Top of the priority list are people who live and work in care homes, followed by people over the age of 80 and frontline health and social care workers – including NHS staff.

Next on the list are people over the age 75, and the fourth group are people aged 70 and those classed as clinically extremely vulnerable.

This last group – who are the same as those who have been advised to shield – includes people such as organ transplant recipients and cancer patients.

Johnson said of the top four priority groups: "If we succeed in vaccinating all those groups, we will have removed huge numbers of people from the path of the virus".

"And of course that will eventually enable us to lift many of the restrictions we've endured for so long."

The news comes on the same day the first patients received the Oxford University and AstraZeneca PLC jab, which is now being handed out alongside the Pfizer Inc vaccine.

Johnson referred to the existence of the vaccines as the "one huge difference" in fighting the pandemic now compared to last year.

"We're now rolling out the biggest vaccination programme in our history," he added.

Hospitality businesses have pledged to help with the rollout, offering their spaces which are currently unused due to ongoing closures.

Calling for more grants as premises remain shuttered, UKHospitality Chief Executive Kate Nicholls said businesses are "keen to repay the support shown to us".

She explained: "Our sector is sitting on well-ventilated, Covid-secure spaces such as hotels, conference centres, pubs and restaurants which can be used and businesses are already coming forward to offer locations to expedite a mass vaccination programme."

By Caitlin Doherty, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.